Comparative Effectiveness of Entresto (Sacubitril/Valsartan) Versus ACEi/ARB in de Novo Heart Failure Patients

Clinical trial NCT05963282 · COMPLETED

Trial details

NCT number: NCT05963282
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Study type: OBSERVATIONAL

de Novo Heart Failure

Start date: 2021-11-29
Primary completion: 2022-07-19
Enrollment: 9870

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.